Planet 13 Holdings (PLNH) Total Non-Current Liabilities (2021 - 2026)

Planet 13 Holdings' (PLNH) quarterly Total Non-Current Liabilities came in at $101.9 million in Q1 2026, up 38.23% year-on-year from $73.7 million in Q1 2025, and up 49.65% on a QoQ basis from $68.1 million in Q4 2025.

Planet 13 Holdings (PLNH) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has 6 years of Total Non-Current Liabilities data on file, last reported at $101.9 million in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 38.23% year-over-year to $101.9 million in Q1 2026; TTM through Mar 2026 was $101.9 million, a 38.23% increase from a year earlier, with the FY2025 full-year figure at $68.1 million, down 8.82% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $101.9 million, up from $68.1 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for PLNH reached as high as $102.6 million in Q3 2025 and fell as low as $35.5 million in Q2 2022.
  • Historically, Total Non-Current Liabilities has averaged $61.3 million across 5 years, with a median of $45.6 million in 2024.
  • Across the five-year window, Total Non-Current Liabilities jumped 671.38% in 2022 and slipped 9.71% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $42.7 million in 2022, then increased by 3.19% to $44.1 million in 2023, then soared by 69.36% to $74.7 million in 2024, then declined by 8.82% to $68.1 million in 2025, then soared by 49.65% to $101.9 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $101.9 million in Q1 2026, $68.1 million in Q4 2025, and $102.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 14.92 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 18.28 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.64 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 33.47 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 20.09 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.24 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.26 Bn
10 Planet 13 Holdings 39.35 Mn 23.09 Mn 9.41 Mn 101.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 101.92 Mn
Dec 31, 2025 68.11 Mn
Sep 30, 2025 102.65 Mn
Jun 30, 2025 76.15 Mn
Mar 31, 2025 73.74 Mn
Dec 31, 2024 74.70 Mn
Sep 30, 2024 92.25 Mn
Jun 30, 2024 84.34 Mn
Mar 31, 2024 45.62 Mn
Dec 31, 2023 44.11 Mn
Sep 30, 2023 41.52 Mn
Jun 30, 2023 40.44 Mn
Mar 31, 2023 40.95 Mn
Dec 31, 2022 42.74 Mn
Sep 30, 2022 35.88 Mn
Jun 30, 2022 35.50 Mn
Mar 31, 2022 41.17 Mn
Dec 31, 2021 43.07 Mn
Mar 31, 2021 -7.21 Mn